Erythromycin Tablets 400 mg bottle

País: Austràlia

Idioma: anglès

Font: Department of Health (Therapeutic Goods Administration)

ingredients actius:

Erythromycin ethyl succinate

Disponible des:

Alphapharm Pty Ltd

clase:

Medicine Listed (Export Only)

Informació per a l'usuari

CORDILOX
® SR
C
O
R
D
I
L
O
X
S
R
®
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or pharmacist.
1.
WHY AM I USING CORDILOX SR?
CORDILOX SR contains the active ingredient verapamil hydrochloride.
CORDILOX SR is used for high blood pressure
(hypertension) and angina (chest pain). For more information, see
Section 1. Why am I using CORDILOX SR? in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I USE CORDILOX SR?
Do not use if you have ever had an allergic reaction to CORDILOX SR or
any of the ingredients listed at the end of the CMI.
TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY
OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME
PREGNANT OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before I use
CORDILOX SR? in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with CORDILOX SR and affect how it works.
A list of these medicines is in Section 3. What if I am
taking other medicines? in the full CMI.
4.
HOW DO I USE CORDILOX SR?
•
The usual dose of CORDILOX SR is once daily or they may be taken twice
daily. More instructions can be found in Section 4.
How do I use CORDILOX SR? in the full CMI.
5.
WHAT SHOULD I KNOW WHILE USING CORDILOX SR?
THINGS YOU
SHOULD DO
•
Remind any doctor, dentist or pharmacist you visit that you are using
CORDILOX SR.
•
Tell your doctor if you become pregnant while taking CORDILOX SR.
•
If you are being treated for angina, tell your doctor if the medicine
is not helping.
•
Visit your doctor regularly so that they can check on your progress.
THINGS YOU
SHOULD NOT DO
•
Do not stop using CORDILOX SR or lower the dosage without checking
with your doctor.
•
Do not take CORDILOX SR with grapefruit or its juice.
•
Do not give CORDILOX SR to anyone else, even if they have the same
condition as you.
•
Do not take CORDILOX SR to treat any other complaints unless your
doctor tells you to.

Fitxa tècnica

AUSTRALIAN PRODUCT INFORMATION
CORDILOX
®
_Verapamil hydrochloride tablets _
1
NAME OF THE MEDICINE
Verapamil hydrochloride
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Verapamil hydrochloride is a calcium ion influx inhibitor (slow
channel blocker or calcium ion antagonist).
Each CORDILOX SR film-coated tablet contains 180 mg or 240 mg of
verapamil hydrochloride as the active
ingredient.
Excipients with known effect: None
For the full list of excipients, see
SECTION 6.1 LIST OF EXCIPIENTS
.
3
PHARMACEUTICAL FORM
CORDILOX SR is available for oral administration as light green,
oblong shaped, scored, film-coated tablets
(score and 2 logos on one face and score on the other face) containing
240 mg verapamil hydrochloride and
as old rose, oval shaped, scored, film-coated tablets (‘KNOLL’ on
one face and ‘SR’; score; ‘180’ on the
other face) containing 180 mg verapamil hydrochloride. The tablets are
designed for sustained release of
the drug in the gastrointestinal tract; sustained release
characteristics are not altered when the tablet is
divided in half.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
CORDILOX SR is indicated for the management of hypertension and angina
pectoris.
4.2
DOSE AND METHOD OF ADMINISTRATION
Hypertension
The dose of Cordilox SR should be individualised by titration and the
drug should be administered with
food. The usual daily dose of sustained release verapamil, Cordilox
SR, in clinical trials has been 240 mg
given by mouth once daily in the morning. Some patients may respond to
initial therapy of one 180 mg
tablet once daily. However, initial doses of 120 mg (½ 240 mg tablet)
a day may be warranted in patients
who may have an increased response to verapamil (e.g. elderly, small
people etc.). Upward titration should
be based on therapeutic efficacy and safety evaluated approximately 24
hours after dosing. The
antihypertensive effects of Cordilox SR are evident within the first
week of therapy.
If adequate response is not obtained, the dose may be titrated upward
in the fol